These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 9689422

  • 21. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J, Ghosh NN, Roy K, Chandra R.
    Life Sci; 2007 Feb 27; 80(12):1135-42. PubMed ID: 17234217
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
    Tanis SP, Parker TT, Colca JR, Fisher RM, Kletzein RF.
    J Med Chem; 1996 Dec 20; 39(26):5053-63. PubMed ID: 8978836
    [Abstract] [Full Text] [Related]

  • 23. Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats.
    Fujiwara T, Ohsawa T, Takahashi S, Ikeda K, Okuno A, Ushiyama S, Matsuda K, Horikoshi H.
    Life Sci; 1998 Dec 20; 63(22):2039-47. PubMed ID: 9839548
    [Abstract] [Full Text] [Related]

  • 24. Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice.
    Heitzmann T, Neidlein R, Freund P, Reiff K, Strein K.
    Arzneimittelforschung; 1995 Dec 20; 45(12):1284-8. PubMed ID: 8595085
    [Abstract] [Full Text] [Related]

  • 25. Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas.
    Kawakami Y, Inoue K, Tun T, Hayashi H, Setoyama H, Gu YJ, Cui WX, Imamura M, Iwata H, Ikada Y.
    Cell Transplant; 1997 Dec 20; 6(5):547-50. PubMed ID: 9331511
    [Abstract] [Full Text] [Related]

  • 26. Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.
    Shimabukuro M, Higa S, Shinzato T, Nagamine F, Komiya I, Takasu N.
    Metabolism; 1996 Sep 20; 45(9):1168-73. PubMed ID: 8781306
    [Abstract] [Full Text] [Related]

  • 27. Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.
    Fujiwara T, Okuno A, Yoshioka S, Horikoshi H.
    Metabolism; 1995 Apr 20; 44(4):486-90. PubMed ID: 7723671
    [Abstract] [Full Text] [Related]

  • 28. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
    Aoki K, Kikuchi T, Mukasa K, Ito S, Nakajima A, Satoh S, Okamura A, Sekihara H.
    Endocr J; 2000 Dec 20; 47(6):799-804. PubMed ID: 11228057
    [Abstract] [Full Text] [Related]

  • 29. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.
    Aoki K, Saito T, Satoh S, Mukasa K, Kaneshiro M, Kawasaki S, Okamura A, Sekihara H.
    Diabetes; 1999 Aug 20; 48(8):1579-85. PubMed ID: 10426376
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives.
    Madhavan GR, Chakrabarti R, Vikramadithyan RK, Mamidi RN, Balraju V, Rajesh BM, Misra P, Kumar SK, Lohray BB, Lohray VB, Rajagopalan R.
    Bioorg Med Chem; 2002 Aug 20; 10(8):2671-80. PubMed ID: 12057656
    [Abstract] [Full Text] [Related]

  • 33. Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs.
    Kiyota Y, Kondo T, Maeshiba Y, Hashimoto A, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S.
    Arzneimittelforschung; 1997 Jan 20; 47(1):22-8. PubMed ID: 9037439
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivative, FPFS-410.
    Norisada N, Masuzaki H, Fujimoto M, Inoue G, Hosoda K, Hayashi T, Watanabe M, Muraoka S, Yoneda F, Nakao K.
    Metabolism; 2004 Dec 20; 53(12):1532-7. PubMed ID: 15562395
    [Abstract] [Full Text] [Related]

  • 36. Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone.
    Herman JR, Dethloff LA, McGuire EJ, Parker RF, Walsh KM, Gough AW, Masuda H, de la Iglesia FA.
    Toxicol Sci; 2002 Jul 20; 68(1):226-36. PubMed ID: 12075125
    [Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics of troglitazone.
    Loi CM, Young M, Randinitis E, Vassos A, Koup JR.
    Clin Pharmacokinet; 1999 Aug 20; 37(2):91-104. PubMed ID: 10496299
    [Abstract] [Full Text] [Related]

  • 38. Troglitazone-induced heart and adipose tissue cell proliferation in mice.
    Breider MA, Gough AW, Haskins JR, Sobocinski G, de la Iglesia FA.
    Toxicol Pathol; 1999 Aug 20; 27(5):545-52. PubMed ID: 10528634
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.